Loading stock…

ALK-Abelló A/S (ALK B) Stock Verdict & Ratings | Investment Bastion

Stock Verdict·Updated today

ALK-Abelló A/S

ALK BMarket cap $7.61BPrice $34.5

Country🇩🇰Denmark

SectorHealthcare

IndustryPharmaceuticals

Develops and manufactures allergy immunotherapy treatments that retrain the immune system rather than just masking symptoms. One of the world's few pure-play allergy vaccine makers, treating everything from hay fever to life-threatening allergies with tablets and injections.

In Bastion Portfolios?

52W Return+7%Global Market +16%?

01Key Ratings

How does this stock score across Bastion factors?

Growth

Historical Revenue

Rev CAGR (3y)+15%8

Revenue Forecast

Rev CAGR (1y)+11%6

Rev CAGR (3y)+14%8

Rev CAGR (5y)+14%8

Earnings Forecast

EPS Growth Y+1+15%8

EPS Growth Y+2+13%7

EPS Growth Y+3+14%7

Quality

Margins

EBIT Margin27%8

Net Income Margin20%8

Free Cash Flow Margin28%9

Debt

Net Debt/EBITDA-0.610

Efficiency

ROE21%8

ROA15%9

Earnings Stability1010

GEAR+VERY STRONG97

Overall rating across all five factors

Value

Price Multiples

P/E Ratio (Forward)332

P/E Ratio (Forward 3y)272

P/BV7.32

EV Multiples

EV/EBITDA Fwd222

EV/EBIT Fwd263

Yield

Free Cash Flow Yield3.7%5

Dividend Yield0.7%2

Momentum

Short term

1 month return+15%10

3 month return-6%5

YTD return+2%5

Mid term

Price vs 52wHigh85%6

1 year return+9%6

Long term

3 year return+188%9

5 year return+69%7

Risk Shield

Price Risk

Beta0.39

Volatility27%8

Free Cash Flow

Free Cash Flow Margin28%9

Free Cash Flow Yield3.7%5

Quality

ROCE24%9

Earnings Stability1010

Net Debt/EBITDA-0.610

02Growth

Is it actually growing, and how fast?

ALK BALK-Abelló A/S

Revenue FY25$993M

GROWTH RATING↗

STRONG75 / 100

REVENUE GROWTH▾SCORE

Revenue, last 3Y, CAGR+15%8

Revenue, next 1Y+11%6

Revenue, next 3Y, CAGR+14%8

Revenue, next 5Y, CAGR+14%8

EARNINGS FORECAST▾SCORE

EPS growth, FY26E+15%8

EPS growth, FY27E+13%7

EPS growth, FY28E+14%7

GROWTH ASSESSMENT

STRENGTHS

It out-grows 75% of companies worldwide.

Revenue grew 15%/yr over the last 3 years, ahead of 70% of companies worldwide.8/10

Revenue is set to grow 14%/yr over the next 3 years, ahead of most of the market.7/10

Revenue grew 15%/yr over the last 3 years and is set to keep growing around 14%/yr.

The runway holds up: revenue is set to grow 14%/yr over five years.8/10

Earnings are set to grow in step with sales (EPS about 14%/yr vs revenue 14%/yr).

WATCH

None flagged.

WEAKNESSES

None flagged.

BOTTOM LINE

Elite Compounder

A top-tier grower.

03Price Momentum

Is the market behind it right now?

ALK BALK-Abelló A/S

Total return Current429%

Price return Current426%

MOMENTUM RATING↗

STRONG74 / 100

SHORT-TERM RETURNS▾SCORE

1-month return+15%10

3-month return-6%5

YTD return+2%5

MID & LONG-TERM▾SCORE

% of 52-week high85%6

1-year return+9%6

3-year return+188%9

5-year return+69%7

MOMENTUM ASSESSMENT

STRENGTHS

Magnificent long-term results. Long-term holders have seen +188% over three years and +69% over five, ahead of 70% of the market.

Strong recent results. The stock is outperforming over the past month (+15%).

WATCH

It's up 9% over the past year, but 15% below its 52-week high. That is a touch ahead of the market.

Returns sit at the market level over three months (-6%) and so far this year (+2%).

WEAKNESSES

None flagged.

BOTTOM LINE

Steady Compounder

Dependable multi-year returns with a calmer near-term tape. A reliable long-term trend rather than a short-term breakout.

04Value

Are you paying a fair price for it?

Stop guessing on ALK-Abelló A/S. Get the full investment case.

Premium

$20.75/month

Billed annually at $249/year $348

✓
Stock VerdictValuation and investment strategy for 4,000+ stocks. Days of hedge fund analyst research, done in 2 minutes.
✓
RadarFind your next investment idea: top-ranked stocks across all 9 Bastion strategies.
✓
Portfolio ManagerCheck if Bastion algorithms added the stock you care about to their portfolios.

Secure via Stripe

Trusted by 1,000+ investors in our community

Loading charts…

02Growth

Is it actually growing, and how fast?

ALK BALK-Abelló A/S

Revenue FY25$993M

GROWTH RATING↗

STRONG75 / 100

REVENUE GROWTH▾SCORE

Revenue, last 3Y, CAGR+15%8

Revenue, next 1Y+11%6

Revenue, next 3Y, CAGR+14%8

Revenue, next 5Y, CAGR+14%8

EARNINGS FORECAST▾SCORE

EPS growth, FY26E+15%8

EPS growth, FY27E+13%7

EPS growth, FY28E+14%7

GROWTH ASSESSMENT

STRENGTHS

It out-grows 75% of companies worldwide.

Revenue grew 15%/yr over the last 3 years, ahead of 70% of companies worldwide.8/10

Revenue is set to grow 14%/yr over the next 3 years, ahead of most of the market.7/10

Revenue grew 15%/yr over the last 3 years and is set to keep growing around 14%/yr.

The runway holds up: revenue is set to grow 14%/yr over five years.8/10

Earnings are set to grow in step with sales (EPS about 14%/yr vs revenue 14%/yr).

WATCH

None flagged.

WEAKNESSES

None flagged.

BOTTOM LINE

Elite Compounder

A top-tier grower.

03Price Momentum

Is the market behind it right now?

ALK BALK-Abelló A/S

Total return Current429%

Price return Current426%

MOMENTUM RATING↗

STRONG74 / 100

SHORT-TERM RETURNS▾SCORE

1-month return+15%10

3-month return-6%5

YTD return+2%5

MID & LONG-TERM▾SCORE

% of 52-week high85%6

1-year return+9%6

3-year return+188%9

5-year return+69%7

MOMENTUM ASSESSMENT

STRENGTHS

Magnificent long-term results. Long-term holders have seen +188% over three years and +69% over five, ahead of 70% of the market.

Strong recent results. The stock is outperforming over the past month (+15%).

WATCH

It's up 9% over the past year, but 15% below its 52-week high. That is a touch ahead of the market.

Returns sit at the market level over three months (-6%) and so far this year (+2%).

WEAKNESSES

None flagged.

BOTTOM LINE

Steady Compounder

Dependable multi-year returns with a calmer near-term tape. A reliable long-term trend rather than a short-term breakout.

04Value

Are you paying a fair price for it?

Stop guessing on ALK-Abelló A/S. Get the full investment case.

Premium

$20.75/month

Billed annually at $249/year $348

✓
Stock VerdictValuation and investment strategy for 4,000+ stocks. Days of hedge fund analyst research, done in 2 minutes.
✓
RadarFind your next investment idea: top-ranked stocks across all 9 Bastion strategies.
✓
Portfolio ManagerCheck if Bastion algorithms added the stock you care about to their portfolios.

Secure via Stripe

Trusted by 1,000+ investors in our community